Immune response to a hepatitis B DNA vaccine in Aotus monkeys: A comparison of vaccine formulation, route, and method of administration

Molecular Medicine

Volumn 4, Issue 2, 1998, Pages 109-118

  Gramzinski, Robert A ^a,b   Brazolot Millan, Cynthia L ^c   Obaldia, Nicanor ^b,d   Hoffman, Stephen L ^a   Davis, Heather L ^c,e  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b Gorgas Memorial Institute   (Panama)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d ProMed Trading Inc   (Panama)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLFECTIN; DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HEPATITIS B; HUMORAL IMMUNITY; IMMEDIATE EARLY GENE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

EID: 7144256527     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401734     Document Type: Article

References (38)

1. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. (1997) DNA vaccines. Ann. Rev. Immunol. 15: 617-648.
2. Davis HL, Brazolot Millan CL. (1998) DNA-based immunization. Blood Cell Biochem. (in press).
3. Donnelly JJ, Ulmer JB, Liu MA. (1998) DNA vaccines. Life Sci. 60: 163-172.
4. Gregoriadis G, Saffie R, de Souza JB. (1997) Liposome-mediated DNA vaccination. FEBS Lett. 402: 107-110.
5. Boyer JD, Ugen KE, Wang B, et al. (1997) Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med. 3: 526-532.
6. Davis HL, McCluskie MJ, Gerin JL, Purcell RH. (1996) DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. U.S.A. 93: 7213-7218.
7. Fuller DH, Murphey-Corb M, Clements J, Barnett S, Haynes JR. (1996) Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J. Med. Primatol. 25: 236-241.
8. Lekutis C, Shiver JW, Liu MA, Letvin NL. (1997) HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. J. Immunol. 158: 4471-4477.
9. Liu MA, Yasutomi Y, Davies M-E, et al. (1996) Vaccination of mice and nonhuman primates using HIV-gene-containing DNA. In: Giraldo G, Bolognesi GP, Salvatore M, Beth-Giraldo E (eds). Development and Applications of Vaccines and Gene Therapy in AIDS. vol. 48. Karger, Basel, pp. 100-104.
10. Liu MA, McClements W, Ulmer JB, Shiver J, Donnelly J. (1997) Immunization of non-human primates with DNA vaccines. Vaccine 15: 909-912.
11. Lu S, Arthos J, Montefiori DC, et al. (1996) Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70: 3978-3991.
12. Prince AM, Whalen R, Brotman B. (1997) Successful DNA-based HBV immunization of new-horn chimpanzees. Vaccine 15: 916-919.
13. Centers for Disease Control. (1987) Recommendations of the Immunization Practises Advisory Committee. Update on hepatitis B prevention. MMWR Morb. Mortal. Wkly. Rep. 36: 353.
14. Calandra GB, West DJ. (1993) Recommendations for prevention of hepatitis B with vaccine. In: Ellis RW (ed). Hepatitis B Vaccines in Clinical Practice. Marcel Dekker, Inc., New York, pp. 1-16.
15. Davis HL. (1996) DNA-based vaccination against hepatitis B virus. Adv. Drug Delivery 21: 33-47.
16. Guan R. (1989) Comparison of the immnnogenicity of the 5 μg dose and 10 μg dose MSD rDNA hepatitis B vaccine (Hepavac II). Epidemiol. News Bull. 15: 24-26.
17. Gramzinski RA, Maris DC, Obaldia N, et al. (1996) Optimization of antibody responses of a malaria DNA vaccine in Aotus monkeys. Vaccine Res. 5: 173-183.
18. Gramzinski RA, Maris DC, Doolan D. et al. (1997) Malaria DNA vaccines in Aotus monkeys. Vaccine 15: 913-915.
19. Jiao S, Williams P, Berg RK, et al. (1992) Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene Ther. 3: 21-33.
20. Yasutomi Y, Robinson HL, Lu SS, et al. (1996) Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol 70: 678-681.
21. Davis HL, Michel ML, Mancini M, Schleef M, Whalen RG. (1994) Direct gene transfer in muscle with plasmid DNA for the purpose of nucleic acid immunization. Vaccine 12: 1503-1509.
22. Doe B, Selby S, Barnett J, Baenziger J, Walker CM. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. U.S.A. 93: 8578-8583.
23. Corr M, Lee DJ, Carson DA, Tighe H. (1996) Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J. Exp. Med. 184: 1555-1560.
24. Ulmer JB, Deck RR, DeWitt CM, Donnelly JJ, Liu MA. (1996) Generation of MHC class-I restricted T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89: 59-67.
25. Iwasaki A, Torres CAT, Ohashi P, Robinson HL, Barber BH. (1997) The dominant role of bone-marrow derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159: 11-14.
26. Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT. (1997) Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J. Leukoc. Biol. 61: 125-132.
27. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD. (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 2: 1122-1128.
28. McCluskie MJ, Davis HL (1998) DNA-based immunization of mice against HBV by intramuscular injection requires free DNA. In: Brown F, Burton D, Doherty P, Mekalanos J, Norrby E (eds). Vaccines 97: Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbour Laboratory Press, New York, pp. 125-130.
29. Wolff JA, Malone RW, Williams P, et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468.
30. Krieg AM, Yi A-K, Matson S, et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
31. Klinman DM, Yamshchikov G, Ishigatsubo Y. (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158: 3635-3639.
32. Sato Y, Roman M, Tighe H, et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354.
33. Roman M, Martinorozco E, Goodman S, et al. (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3: 849-854.
34. Davis HL, Weeratna R, Waldschmidt TJ, Schorr J, Krieg AM. (1998) CpG DNA is a potent adjuvant in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160: 870-876.
35. Gribaudo G, Ravaglia S, Caliendo A, et al. (1993) Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197: 303-311.
36. Harms JS, Splitter GA. (1995) Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6: 1291-1297.
37. Cowdery JS, Chace JH, Yi A-K, Krieg AM. (1996) Bacterial DNA induces NK cells to produce interferon-γui vivo and increases the toxicity of lipopolysaccharide. J. Immunol. 156: 4570-4575.
38. Halpern MD, Kurlander RJ, Pisetsky DS. (1996) Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell Immunol. 167: 72-78.